Photocure ASA (LON: 0IMT)

Market Cap	99.15M
Revenue (ttm)	37.29M
Net Income (ttm)	1.00M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	98.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,961
Average Volume	1,100
Open	51.70
Previous Close	51.40
Day's Range	50.80 - 51.70
52-Week Range	40.85 - 71.90
Beta	0.78
RSI	30.57
Earnings Date	Feb 19, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical p...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 102
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IMT

Financial Performance

Financial numbers in NOK